Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Aguiar, Anna Caroline C ^a,b   Pereira, Dhelio B ^c   Amaral, Nayra S ^b   De Marco, Luiz ^b   Krettli, Antoniana U ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Centro de Medicina Tropical de Rondônia   (Brazil)

Author keywords

Anti malarials; Chloroquine resistance; Plasmodium falciparum; Plasmodium vivax; Resistance

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; CHLOROQUINE; MEFLOQUINE; MEMBRANE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PFCRT PROTEIN; PFMDR1 PROTEIN; PROTOZOAL PROTEIN; PVMDR1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANGOLA; ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; BLOOD CELL COUNT; BLOOD SMEAR; BRAZIL; CODON; EX VIVO STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PARASITE CULTIVATION; PARASITE ISOLATION; PARASITE PREVALENCE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; YOUNG ADULT;

ADULT; ANTIMALARIALS; ARTEMISININS; BRAZIL; CHLOROQUINE; DNA, PROTOZOAN; DRUG RESISTANCE; FEMALE; GENOTYPE; HUMANS; INHIBITORY CONCENTRATION 50; MALARIA; MALE; MEFLOQUINE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTATION, MISSENSE; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PROTOZOAN PROTEINS;

EID: 84896127533     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-73     Document Type: Article

References (38)

1. WHO, World Malaria Report 2011 Genev: World Malaria Report 2011 http://www.who.int/malaria/world-malaria-report-2011/9789241564403-eng.pdf. Accessed: 27/05/2013
2. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, del Portillo HA, Lancet Infect Dis 2009 9 555 566 10.1016/S1473-3099(09)70177-X 19695492
3. WHO, World Malaria Report 2012 Geneva: World Health Organization 2012Accessed: 27/09/2013http://www.who.int/malaria/publications/world-malaria- report-2012/report/en/index.html
4. Ministério da Saúde 2010 http://bvsms.saude.gov.br/bvs/ publicacoes/guia-pratico-malaria.pdf
5. Therapeutic response of multidrug-resistant Plasmodium falciparum and P. Vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia. Ratcliff A, Siswantoro H, Kenangalem E, Wuwung M, Brockman A, Edstein MD, Laihad F, Ebsworth EP, Anstey NM, Tjitra E, Price RN, Trans R Soc Trop Med Hyg 2007 4 351 359 (Pubitemid 46205894)
6. A trial of combination anti-malarial therapies in children from Papua New Guinea. Karunajeewa HA, Mueller I, Senn M, Lin E, Law I, Gomorrai PS, Oa O, Griffin S, Kotab K, Suano P, Tarongka N, Ura A, Lautu D, Page-Sharp M, Wong R, Salman S, Siba P, Ilett KF, Davis TM, N Engl J Med 2008 24 2545 2557
7. Resistance to chloroquine by Plasmodium vivax at Alor in the Lesser Sundas Archipelago in eastern Indonesia. Manoempil P, Baird JK, Sutanto I, Suprijanto S, Nurhayati, Am J Trop Med Hyg 2009 2 338 342
8. Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms. Suwanarusk R, Russell B, Chavchich M, Chalfein F, Kenangalem E, Kosaisavee V, Prasetyorini B, Piera KA, Barends M, Brockman A, Lek-Uthai U, Anstey NM, Tjitra E, Nosten F, Cheng Q, Price RN, PLoS One 2007 10 1089
9. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Price RN, Douglas NM, Anstey NM, Curr Opin Infect Dis 2009 22 430 435 10.1097/QCO.0b013e32832f14c1 19571748
10. Severe Plasmodium vivax malaria, Brazilian Amazon. Alexandre MA, Ferreira CO, Siqueira AM, Magalhães BL, Mourão MP, Lacerda MV, Alecrim MD, Emerg Infect Dis 2010 16 1611 1614 10.3201/eid1610.100685 20875292
11. Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. Andrade BB, Reis-Filho A, Souza-Neto SM, Clarêncio J, Camargo LM, Barral A, Barral-Netto M, Malar J 2010 9 13 10.1186/1475-2875-9-13 20070895
12. Risk factors and characterization of Plasmodium vivax-associated admissions to pediatric intensive care units in the Brazilian Amazon. Lanca EF, Magalhaes BM, Vitor-Silva S, Siqueira AM, Benzecry SG, Alexandre MA, Brien CO, Bassat Q, Lacerda MV, PLoS One 2012 7 35406 10.1371/journal.pone.0035406 22523591
13. High frequency of PfCRT 76T in two Malian villages and its prevalence in severe relative to non-severe malaria. Wélé M, Djimdé AA, Guindo A, Beavogui AH, Traoré IZ, Sadou A, Blaise D, Diallo DA, Wellems TE, Doumbo OK, Acta Trop 2011 119 11 13 10.1016/j.actatropica.2011.01.002 21300016
14. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
15. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Miotto O, Almagro-Garcia J, Manske M, Macinnis B, Campino S, Rockett KA, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Duong S, Nguon C, Chuor CM, Saunders D, Se Y, Lon C, Fukuda MM, Amenga-Etego L, Hodgson AV, Asoala V, Imwong M, Takala-Harrison S, Nosten F, Su XZ, Ringwald P, Ariey F, Dolecek C, Hien TT, Boni MF, et al. Nat Genet 2013 45 648 655 10.1038/ng.2624 23624527
16. Chloroquine resistant vivax malaria in a pregnant woman on the western border of Thailand. Rijken MJ, Boel ME, Russell B, Imwong M, Leimanis ML, Phyo AP, Muehlenbachs A, Lindegardh N, McGready R, Rénia L, Snounou G, Singhasivanon P, Nosten F, Malar J 2011 10 113 10.1186/1475-2875-10-113 21545737
17. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region. Alecrim MG, Alecrim W, Macedo V, Rev Soc Bras Med Trop 1999 32 67 68 9927829 (Pubitemid 29006271)
18. In vitro chloroquine resistance for Plasmodium vivax isolates from the Western Brazilian Amazon. Chehuan YF, Costa MR, Costa JS, Alecrim MG, Nogueira F, Silveira H, Brasil LW, Melo GC, Monteiro WM, Lacerda MV, Malar J 2013 12 226 10.1186/1475-2875-12-226 23819884
19. Chloroquine resistance in Plasmodium falciparum falciparum malaria parasites conferred by pfcrt mutations. Sidhu AB, Verdier-Pinard D, Fidock DA, Science 2002 298 210 213 10.1126/science.1074045 12364805
20. Epidemiology of drug-resistant malaria. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR, Lancet Infect Dis 2002 2 209 218 10.1016/S1473-3099(02)00239-6 11937421 (Pubitemid 34464751)
21. Chloroquine-resistant malaria. Wellems TE, Plowe CV, J Infect Dis 2001 184 770 776 10.1086/322858 11517439 (Pubitemid 32826429)
22. Chloroquine resistance of Plasmodium falciparum in Brazil detected by a simple in vitro method. Rieckmann KH, López Antuñano FJ, Bull World Health Organ 1971 45 157 167 4945631
23. Micro test for assaying sensitivity of Plasmodium vivax in vitro. Renapurkar DM, Pradhan VR, Sutar NK, Deshmukh RA, Pandit CH, Marathe SN, Chemotherapy 1989 3 160 163 (Pubitemid 19161227)
24. Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to anti-malarials in areas where P. Vivax is endemic. Russell BM, Udomsangpetch R, Rieckmann KH, Kotecka BM, Coleman RE, Sattabongkot J, Antimicrob Agents Chemother 2003 47 170 173 10.1128/AAC.47.1. 170-173.2003 12499187 (Pubitemid 36070360)
25. Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected blood. Sriprawat K, Kaewpongsri S, Suwanarusk R, Leimanis ML, Lek-Uthai U, Phyo AP, Snounou G, Russell B, Renia L, Nosten F, Malar J 2009 8 115 10.1186/1475-2875-8-115 19490618
26. Human malaria parasites in continuous culture. Trager W, Jensen J, Science 1976 193 673 675 10.1126/science.781840 781840
27. Real-time PCR for detection and identification of Plasmodium spp. Mangold KA, Manson RU, Koay ES, Stephens L, Regner M, Thomson RB Jr, Peterson LR, Kaul KL, J Clin Microbiol 2005 43 2435 2440 10.1128/JCM.43.5.2435-2440.2005 15872277 (Pubitemid 40656261)
28. Comparative ex vivo activity of novel endoperoxides in multidrug-resistant Plasmodium falciparum and P. Vivax. Marfurt J, Chalfein F, Prayoga P, Wabiser F, Wirjanata G, Sebayang B, Piera KA, Wittlin S, Haynes RK, Möhrle JJ, Anstey NM, Kenangalem E, Price RN, Antimicrob Agents Chemother 2012 56 5258 5263 10.1128/AAC.00283-12 22850522
29. Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. Vivax. Marfurt J, Chalfein F, Prayoga P, Wabiser F, Kenangalem E, Piera KA, Fairlie DP, Tjitra E, Anstey NM, Andrews KT, Price RN, Antimicrob Agents Chemother 2011 55 961 966 10.1128/AAC.01220-10 21135175
30. SVS, Serviço de Vigilância Sanitária 2013 http://dw.saude.gov.br/gsid/servlet/mstr Accessed: 27/09/2013
31. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naudé B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE, Mol Cell 2000 6 861 871 10.1016/S1097-2765(05)00077-8 11090624
32. Use of a colorimetric (DELI) test for the evaluation of chemoresistance of Plasmodium falciparum and Plasmodium vivax to commonly used anti-plasmodial drugs in the Brazilian Amazon. Carvalho LJ, Daniel-Ribeiro CT, de Fátima Ferreira-da-Cruz M, Bianco-Junior C, Druilhe P, Brasseur P, Siqueira MJ, das Graças Alecrim M, Pratt-Riccio LR, Chehuan YF, Siqueira MJ, Malar J 2013 12 281 10.1186/1475-2875-12-281 23937727
33. Chloroquine-resistant Plasmodium vivax in the Brazilian Amazon. de Santana Filho FS, Arcanjo AR, Chehuan YM, Costa MR, Martinez-Espinosa FE, Vieira JL, Barbosa M, Alecrim WD, Alecrim MD, Emerg Infect Dis 2007 13 1125 1126 10.3201/eid1307.061386 18214203 (Pubitemid 47048104)
34. Analysis of single-nucleotide polymorphisms in the crt-o and mdr1 genes of Plasmodium vivax amongchloroquine-resistant isolates from the Brazilian Amazon region. Orjuela-Sánchez P, de Santana Filho FS, Machado-Lima A, Chehuan YF, Costa MR, Alecrim M, del Portillo HA, Antimicrob Agents Chemother 2009 53 3561 3564 10.1128/AAC.00004-09 19451296
35. Improved assessment of Plasmodium vivax response to anti-malarial drugs by a colorimetric double-site Plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay. Druilhe P, Brasseur P, Blanc C, Makler M, Antimicrob Agents Chemother 2007 51 2112 2116 10.1128/AAC.01385-06 17387158 (Pubitemid 46903102)
36. Increased expression levels of the pvcrt-o and pvmdr1 genes in a patient with severe Plasmodium vivax malaria. Fernández-Becerra C, Pinazo MJ, González A, Alonso PL, del Portillo HA, Gascón J, Malar J 2009 8 55 10.1186/1475-2875-8-55 19341456
37. Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms. Suwanarusk R, Russell B, Chavchich M, Chalfein F, Kenangalem E, Kosaisavee V, Prasetyorini B, Piera KA, Barends M, Brockman A, Lek-Uthai U, Anstey NM, Tjitra E, Nosten F, Cheng Q, Price RN, PLoS One 2007 2 1089 10.1371/journal.pone.0001089 17971853 (Pubitemid 351566688)
38. Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum. Lek-Uthai U, Suwanarusk R, Ruengweerayut R, Skinner-Adams TS, Nosten F, Gardiner DL, Boonma P, Piera KA, Andrews KT, Machunter B, McCarthy JS, Anstey NM, Price RN, Russell B, Antimicrob Agents Chemother 2008 7 2435 2441 (Pubitemid 351915673)